[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nuvectis Pharma Inc (NVCT)

Nuvectis Pharma Inc (NVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nuvectis Pharma Inc 1 BRIDGE PLAZA SUITE 275 FORT LEE NJ 07024 USA

www.nuvectis.com Employees: 13 P: 201-614-3150

Sector:

Medical

Description:

Nuvectis Pharma Inc. is a biopharmaceutical company. It focused on the development of innovative precision medicines for serious conditions of unmet medical need in oncology. Nuvectis Pharma Inc. is based in Fort Lee, NJ.

Key Statistics

Overview:

Market Capitalization, $K 366,589
Enterprise Value, $K 334,959
Shares Outstanding, K 26,526
Float, K 18,953
% Float 71.45%
Short Interest, K 1,581
Short Float 5.96%
Days to Cover 13.62
Short Volume Ratio 0.49
% of Insider Shareholders 28.55%
% of Institutional Shareholders 96.77%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -26,440 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,050 K
EBIT, $ -28,270 K
EBITDA, $ -28,270 K

Growth:

1-Year Return 71.68%
3-Year Return -18.47%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.26 on 05/05/26
Next Earnings Date 08/04/26
Earnings Per Share ttm -1.31
EPS Growth vs. Prev Qtr 16.13%
EPS Growth vs. Prev Year 3.70%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

NVCT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -161.00%
Return-on-Assets % -98.88%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 24.50
Book Value/Share 0.51
Interest Coverage -1.81
60-Month Beta -0.07
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.